Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-Current Assets (2019 - 2023)

Historic Non-Current Assets for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $91.3 million.

  • ADC Therapeutics' Non-Current Assets fell 251.76% to $91.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $91.3 million, marking a year-over-year decrease of 251.76%. This contributed to the annual value of $83.2 million for FY2022, which is 8951418.26% up from last year.
  • As of Q3 2023, ADC Therapeutics' Non-Current Assets stood at $91.3 million, which was down 251.76% from $94.5 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Non-Current Assets registered a high of $96.0 million during Q2 2022, and its lowest value of $14717.0 during Q2 2020.
  • For the 5-year period, ADC Therapeutics' Non-Current Assets averaged around $61.4 million, with its median value being $76.6 million (2021).
  • Per our database at Business Quant, ADC Therapeutics' Non-Current Assets surged by 47522785.21% in 2021 and then plummeted by 691.37% in 2023.
  • ADC Therapeutics' Non-Current Assets (Quarter) stood at $15076.0 in 2019, then increased by 0.21% to $15107.0 in 2020, then skyrocketed by 75206.13% to $11.4 million in 2021, then surged by 630.92% to $83.2 million in 2022, then rose by 9.8% to $91.3 million in 2023.
  • Its last three reported values are $91.3 million in Q3 2023, $94.5 million for Q2 2023, and $87.7 million during Q1 2023.